Stay updated on Inhaled Treprostinil in PH-COPD Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in PH-COPD Clinical Trial page.

Latest updates to the Inhaled Treprostinil in PH-COPD Clinical Trial page
- Check3 days agoChange DetectedThe Study Details Locations were updated: new sites across Alabama, California, Florida, Georgia, Illinois, Indiana, Kentucky, Maryland, Massachusetts, Michigan, New York, North Carolina, Ohio, Pennsylvania, South Carolina, Virginia, Wisconsin, plus Forli, Italy, were added and the revision moved from v3.3.2 to v3.3.3.SummaryDifference2%

- Check10 days agoChange DetectedA new study location was added in Forlì, Italy, bringing the total number of locations to 31. The page now lists the Forlì site among study locations.SummaryDifference0.5%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedThe government funding operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedNo significant content or functionality changes were detected on the study details page; the page appears largely unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

Stay in the know with updates to Inhaled Treprostinil in PH-COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in PH-COPD Clinical Trial page.